Physician Attitudes Toward Dissemination of Optical Spectroscopy Devices for Cervical Cancer Control: An Industrial-Academic Collaborative Study

Schomacker, 1992, Ultraviolet laser-induced fluorescence of colonic polyps, Gastroenterology, 102, 1155, 10.1016/0016-5085(92)90752-K Vo-Dinh, 1995, In vivo cancer diagnosis of the esophagus using differential normalized flourescence (DNF) indices, Lasers Surg Med, 16, 41, 10.1002/lsm.1900160106 Anidjar, 1998, The role of laser-induced autofluorescence spectroscopy in bladder tumor detection, Ann N Y Acad Sci, 838, 130, 10.1111/j.1749-6632.1998.tb08194.x Lam, 1992, Detection of dysplasia and carcinoma in situ by ratio fluorometry, Am Rev Respir Dis, 146, 1458, 10.1164/ajrccm/146.6.1458 Burke, 1999, Identification of squamous intraepithelial lesions: fluorescence of cervical tissue during colposcopy, J Low Genit Tract Dis, 3, 159, 10.1046/j.1526-0976.1999.08109.x Burke, 1996, Use of autofluorescence of cells to evaluate cervical neoplasia, J Gynecol Tech, 2, 90 Chang, 2002, Optimal excitation wavelengths for discrimination of cervical neoplasia, IEEE Trans Biomed Eng, 49, 1102, 10.1109/TBME.2002.803597 Chang, 2005, Combined reflectance and fluorescence spectroscopy for in vivo detection of cervical pre-cancer, J Biomed Optics, 10, 024, 10.1117/1.1899686 DeSantis, 2007, Spectroscopic imaging as a triage test for cervical disease: a prospective multicenter clinical trial, J Low Genit Tract Dis, 11, 18, 10.1097/01.lgt.0000230207.50495.05 Ferris, 2001, Multimodal hyperspectral imaging of the noninvasive diagnosis of cervical neoplasia, J Low Genit Tract Dis, 5, 65 Freeberg, 2007, The clinical effectiveness of fluorescence and reflectance spectroscopy for the in vivo diagnosis of cervical neoplasia: an analysis by phase of trial design, Gynecol Oncol, 107, S270, 10.1016/j.ygyno.2007.07.009 Georgakoudi, 2002, Trimodal spectroscopy for the detection and characterization of cervical precancers in vivo, Am J Obstet Gynecol, 186, 374, 10.1067/mob.2002.121075 Huh, 2004, Optical detection of high-grade cervical intraepithelial neoplasia in vivo: results of a 604-patient study, Am J Obstet Gynecol, 190, 1249, 10.1016/j.ajog.2003.12.006 Mirabal, 2002, Reflectance spectroscopy for in vivo detection of cervical precancer, J Biomed Optics, 7, 587, 10.1117/1.1502675 Mourant, 2007, In vivo light scattering measurements for detection of precancerous conditions of the cervix, Gynecol Oncol, 105, 439, 10.1016/j.ygyno.2007.01.001 Nordstrom, 2001, Identification of cervical intraepithelial neoplasia (CIN) using UV-excited fluorescence and diffuse-reflectance tissue spectroscopy, Lasers Surg Med, 29, 118, 10.1002/lsm.1097 Orfanoudaki, 2005, A clinical study of optical biopsy of the uterine cervix using a multi-spectral imaging system, Gynecol Oncol, 96, 119, 10.1016/j.ygyno.2004.09.013 Parker, 2000, Hyperspectral diagnostic imaging of the cervix: report on a new investigational device, J Low Genit Tract Dis, 4, 119, 10.1097/00128360-200004030-00001 Ramanujam, 1994, Fluorescence spectroscopy—a diagnostic-tool for cervical intraepithelial neoplasia (CIN), Gynecol Oncol, 52, 31, 10.1006/gyno.1994.1007 Ramanujam, 1996, Cervical precancer detection using a multivariate statistical algorithm based on laser-induced fluorescence spectra at multiple excitation wavelengths, Photochem Photobiol, 64, 720, 10.1111/j.1751-1097.1996.tb03130.x Drezek, 2001, Autofluorescence microscopy of fresh cervical-tissue sections reveals alterations in tissue biochmistry with dysplasia, Photochem Photobiol, 73, 636, 10.1562/0031-8655(2001)0730636AMOFCT2.0.CO2 Drezek, 2001, Understanding the contributions of NADH and collagen to cervical tissue fluorescence spectra: modeling, measurements, and implication, J Biomed Optics, 6, 385, 10.1117/1.1413209 Georgakoudi, 2002, NAD(P)H and collagen as in vivo quantitative fluorescent biomarkers of epithelial precancerous changes, Cancer Res, 62, 682 Arifler, 2007, Light scattering from collagen fiber networks: micro-optical properties of normal and neoplastic stroma, Biophys J, 92, 3260, 10.1529/biophysj.106.089839 Brookner, 1997, Safety analysis: relative risks of ultraviolet exposure from fluorescence spectroscopy and colposcopy are comparable, Photochem Photobiol, 65, 1020, 10.1111/j.1751-1097.1997.tb07963.x Cárdenas-Turanzas, 2008, The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings, Cancer Epidemiol Biomarkers Prev, 17, 2865, 10.1158/1055-9965.EPI-08-0137 Drezek, 2003, Light scattering from cervical cells throughout neoplastic progression: influence of nuclear morphology, DNA content, and chromatin texture, J Biomed Optics, 8, 7, 10.1117/1.1528950 Freeberg, 2007, Fluorescence and reflectance device variability throughout the progression of a phase II clinical trial to detect and screen for cervical neoplasia using a fiber optic probe, J Biomed Optics, 12, 034015, 10.1117/1.2750332 Brookner, 1997, Safety analysis: relative risks of ultraviolet exposure from fluorescence spectroscopy and colposcopy are comparable, Photochem Photobiol, 65, 1020, 10.1111/j.1751-1097.1997.tb07963.x Trujillo, 1998, Method to determine tissue fluorescence efficiency in vivo and predict signal to noise ratio for spectrometers, Appl Spectroscopy, 52, 943, 10.1366/0003702981944751 Lee, 2005, Design and preliminary analysis of a study to assess intra-device and inter-device variability of fluorescence spectroscopy instruments for detecting cervical neoplasia, Gynecol Oncol, 99, S98, 10.1016/j.ygyno.2005.07.052 Chang, 2006, Model-based analysis of clinical fluorescence spectroscopy for in vivo detection of cervical intraepithelial neoplasia, J Biomed Optics, 11, 024008, 10.1117/1.2187979 Marin, 2006, Calibration standards for multicenter clinical trials of fluorescence spectroscopy for in vivo diagnosis, J Biomed Optics, 11, 014010, 10.1117/1.2166389 Pikkula, 2007, Instrumentation as a source of variability in the application of fluorescence spectroscopic devices for detecting cervical neoplasia, J Biomed Optics, 12, 034014, 10.1117/1.2745285 Lee, 2005, Design and preliminary analysis of a study to assess intra-device and inter-device variability of fluorescence spectroscopy instruments for detecting cervical neoplasia, Gynecol Oncol, 99, S98, 10.1016/j.ygyno.2005.07.052 Freeberg, 2007, The clinical effectiveness of fluorescence and reflectance spectroscopy for the in vivo diagnosis of cervical neoplasia: an analysis by phase of trial design, Gynecol Oncol, 107, S270, 10.1016/j.ygyno.2007.07.009 Freeberg, 2007, The performance of fluorescence and reflectance spectroscopy for the in vivo diagnosis of cervical neoplasia: point probe versus multispectral approaches, Gynecol Oncol, 107, S248, 10.1016/j.ygyno.2007.07.008 Cardenas-Turanzas, 2007, The clinical effectiveness of optical spectroscopy for the in vivo diagnosis of cervical intraepithelial Neoplasia: where are we?, Gynecol Oncol, S138, 10.1016/j.ygyno.2007.08.082 Basen-Engquist, 2003, Patient distress and satisfaction with optical spectroscopy in cervical dysplasia detection, Am J Obstet Gynecol, 189, 1136, 10.1067/S0002-9378(03)00540-4 Shinn, 2004, Distress after an abnormal Pap smear result: scale development and psychometric validation, Prev Med, 39, 404, 10.1016/j.ypmed.2004.02.004 Pruitt, 2005, Knowledge of cervical dysplasia and human papillomavirus among women seen in a colposcopy clinic, Gynecol Oncol, 99, S236, 10.1016/j.ygyno.2005.07.095 Shuhatovich, 2005, Participant recruitment and motivation for participation in optical technology for cervical cancer screening research trials, Gynecol Oncol, 99, S226, 10.1016/j.ygyno.2005.07.093 Basen-Engquist, 2007, Patient assessment of tests to detect cervical cancer, Int J Technol Assess Health Care, 23, 240, 10.1017/S0266462307070171 Shinn, 2007, A theory-aided dissemination strategy for emerging technologies in cervical cancer screening, Gynecol Oncol, S35, 10.1016/j.ygyno.2007.07.045 Cantor, 2006, Collecting direct non-health-care and time cost data: application screening and diagnosis of cervical cancer, Med Decis Making, 26, 265, 10.1177/027298906288679 Cantor, 1998, Cost-effectiveness analysis of diagnosis and management of cervical squamous intraepithelial lesions, Obstet Gynecol, 91, 270, 10.1016/S0029-7844(97)00623-6 Cantor, 1999, A comparison of C/B ratios from studies using receiver operating characteristic curve analysis, J Clin Epidemiol, 52, 885, 10.1016/S0895-4356(99)00075-X Cantor, 2005, Natural history of cervical intradverse eventspithelial neoplasia: a meta-analysis, Acta Cytol, 49, 405, 10.1159/000326174 Cardenas-Turanzas, 2005, See-and-treat strategy for the diagnosis and management of cervical squamous intradverse eventspithelial lesions, Lancet Oncol, 6, 43, 10.1016/S1470-2045(04)01712-7 Cong, 2007, Bayesian meta-analysis of Papanicolaou smear accuracy, Gynecol Oncol, S133, 10.1016/j.ygyno.2007.08.080 Davies, 2007, Inverse decision theory with applications to screening and diagnosis of cervical intraepithelial neoplasia, Gynecol Oncol, S187, 10.1016/j.ygyno.2007.07.053 Balas, 1998, From appropriate care to evidence-based medicine, Pediatr Ann, 27, 581, 10.3928/0090-4481-19980901-11 Balas, 2003, Information technology and physician decision support Glasgow, 2004, Disseminating effective cancer screening interventions, Cancer, 101, 1239, 10.1002/cncr.20509 Rogers, 2003 Cantor, 2011, Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia: testing a device as an adjunct to colposcopy, Int J Cancer, 128, 1151, 10.1002/ijc.25667 Cardenas-Turanzas, 2007, The clinical effectiveness of optical spectroscopy for the in vivo diagnosis of cervical intraepithelial neoplasia: where are we?, Gynecol Oncol, 107, S138, 10.1016/j.ygyno.2007.08.082 Gravitt, 2010, Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a peri-urban community in Andhra Pradesh, India, PLoS ONE, 5, e13711, 10.1371/journal.pone.0013711 Sasieni, 2010, Has cytology become obsolete as a primary test in screening for cervical cancer?, J Med Screen, 17, 2, 10.1258/jms.2010.010010